why choose us

First received: August 23, 2022

Clinical Trial: Autologous Immune Enhancement Therapy (AIET) for Cancer Patients

Study Status: Completed

Recruit Status: Completed

Condition: Patients With Cancer

Study Type: Interventional


Official Title: Evaluating Safety and Quality of Life of Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals

Brief Summary: This is a retrospective study that included 60 cancer patients who underwent autologous NK cell and CD8 T cell therapy between January 2016 and December 2021

Read more